Lumito
4.82 SEK
-3.51 %
Less than 1K followers
LUMITO
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Lumito
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 949.08 | 750.18 | 148.98 | 270.74 | 293.92 | 106.86 | 7.00 |
| Shares | 0.3 | 0.5 | 0.6 | 1.1 | 1.1 | 1.4 | 3.4 |
| Market cap | 270.5 | 363.7 | 82.1 | 303.9 | 329.9 | 154.5 | 24.1 |
| Enterprise value | 240.0 | 323.7 | 46.6 | - | - | - | - |
| EV/S | - | - | - | - | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | - | - | - | - |
| EV/EBIT | neg. | neg. | neg. | - | - | - | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 4.38 | 3.87 | 0.73 | 2.34 | 3.20 | 1.66 | 0.32 |
| P/S | - | - | - | - | - | 1,544.9 | - |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 91.4 % | 95.7 % | 93.1 % | 95.0 % | 84.9 % | 82.8 % | 86.2 % |
| Gearing ratio | - | - | - | - | - | - | 7.9 % |